WE ARE PIONEERS IN THE WELLNESS INDUSTRY
GET IN TOUCH WITH US01 WHO WE ARE
Global Leaders in Wellness Innovation
The Wellness Access Institute (WAI) are a leading global platform dedicated to advancing wellness through open innovation. We bring together forces across science, academia, and technology to collaboratively tackle enduring consumer wellness challenges.
By uniting our network and fostering collaboration, we create an environment where ideas thrive, solutions are born, and impact is made.
02 WHAT WE DO
We Accelerate Breakthrough Science to Society
WAI empowers innovators and researchers, providing them with a platform to promote their ideas and work. By nurturing a dynamic ecosystem of industry leaders, we ensure the continuous evolution and expansion of the wellness sector.
03 WHY WE DO IT
We Aspire to Build a World Where Wellness is Accessible to All
WAI strongly believes wellness literacy and accessibility are key to lasting change. Using the power of our global community, we work toward driving transformative growth and shaping the future of wellbeing for millions of people worldwide.
MEET THE TEAM
CO-FOUNDERS
Warren Liu
Greg Macpherson
ADVISORY
BOARD
Our advisory board is a collection of doctors, geroscientists, biotechnologists, cardiologists, and other industry experts, unified in a shared mission to reimagine and advance global wellness. Together, we research and refine a wellness vision that’s unequivocally worth accelerating.
Warren Liu
Warren is the architect of the corporate growth strategy, brand portfolio, and product innovation pipeline for the many Wellness Brands. These three things, combined with the vision and strength of Warren’s co-founders, have underpinned impressive track record of industry leadership, wellness innovation, and rapid sales growth.
Warren had more than 20 years of experience living and working across numerous countries in Asia Pacific, and has worked with leading Brands such as Nike, A2 Milk, Swisse, and Bright Dairy.
Warren is the natural founder of our Wellness Access Institute due to his experience with these global consumer brands, his passion for Wellness, and his unique ability to connect trends, capabilities, leaders and consumer needs.
Greg Macpherson
Greg is a rare combination of biotechnologist, futurist and pharmacologist. Throughout his career, a central theme emerged of helping people overcome health challenges, so that they can achieve their potential.
It began when he graduated as a pharmacist and more recently, Greg turned his attention to biotechnology, and specifically towards understanding cellular aging. Aging is now well established as the single biggest risk factor for poor health.
Over the last 10 years, he has spent thousands of hours researching cellular aging and meeting with global anti-aging experts, as they slowly unpack the reasons our cells age.
In 2020 Greg wrote ‘Harnessing the Nine Hallmarks of Aging’. Greg’s book simplifies the latest science behind why we age, making the knowledge that has come from these breakthroughs accessible to all.
Aubrey Levitt
Aubrey Levitt has worked in North American consumer healthcare for over 20 years, from brand and product development to launching startups and advising investors. Aubrey is a microbiome expert, certified health coach, consultant and public speaker.
She is constantly discovering new categories and opportunities. Currently, she and other partners are conducting clinical research for Postbiotics +, a microbiome startup in a new epigenetic category.
Aubrey previously founded Body + Eden, a nutraceuticals and anti-aging product startup that has featured in Oprah Magazine, Elle, Well & Good, and Japan Vogue, as well as collaborating with brands such as One & Only Resorts, Wallpaper Handmade, and The Tracy Anderson Method.
Dr Matt Yousefzadeh
Dr. Matt Yousefzadeh has published over 30 scientific publications with heavy emphasis on cellular senescence and aging.
In 2020, he won the Aging Cell Best Paper Award for his paper on senescent cell accumulation during physiologic and accelerated aging of mice.
This prize is awarded annually for the paper considered to be the most outstanding published in ‘Aging Cell’ in that year.
He is interested in the mechanisms by which endogenous DNA damage and cellular senescence drive aging. Dr. Matt Yousefzadeh has published over 30 scientific publications with heavy emphasis on cellular senescence and aging.
Dr Ross Walker
Dr. Ross Walker is an eminent practising cardiologist with a passion for people and health with 40 years’ experience as a clinician.
For the past 20 years he has been focusing on preventative cardiology & is one of Australia’s leading preventative health experts.
Considered one of the world’s best keynote speakers and life coaches, he is the author of seven best-selling books & a regular health presenter in the Australian Media.
Andrew Gallagher
Andrew Gallagher is the Global Head of Science at Phynova Group, with 15 years of experience in the life sciences sector, developing healthcare products across prescription, over-the-counter, and consumer health markets. His career encompasses the full value chain, from early discovery to clinical development and commercialisation. Gallagher has authored multiple academic publications and medical trade regulations, and holds two patents with the World Intellectual Property Organization (WIPO). Recently, his focus has shifted to nutrition, where he applies pharmaceutical rigor to create consumer health products with measurable impact.
Gallagher holds an MBA in Finance, an MSc in Biology, a BSc with Honours in Biological Science, and a BSc in Chemistry and Cell Biology. He is currently pursuing a part-time PhD in Health Economics at Monash University, researching the cost-effectiveness of lifestyle interventions for chronic diseases.
Kennedy Schaal
A globally recognized expert in genomic selection and breeding, Kennedy specializes in innovative research on Methuselah Flies — fruit flies bred for exceptional longevity. This groundbreaking work integrates artificial intelligence technologies to tackle some of the most complex challenges in longevity research, with the potential to significantly impact global human health and lifespan.
Kennedy holds deep expertise in evolutionary biology, genetics, and age-related disease research, and is also skilled in experimental design and execution.
Dr Jonathan Scheiman
Dr Jonathan Scheiman is the Co-Founder and CEO of FitBiomics, a biotechnology startup focused on decoding the microbiomes of elite athletes to develop the next generation of probiotics and drive innovation in health and nutrition.
He holds a PhD in Biomedical Sciences from New York University, with a research focus in molecular oncology.
A key chapter of his career was spent as a postdoctoral fellow in the lab of Professor George Church at the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he specialized in cutting-edge sequencing technologies and programmable cellular engineering.